Does robitussin make you feel better? new study investigates
NCT ID NCT06716645
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed study looked at how two different Robitussin cough syrup regimens affect quality of life in 244 adults with coughs from the common cold. One group used a single daytime/nighttime syrup, while the other used separate daytime and nighttime syrups. Researchers measured changes in symptoms and daily functioning using a standard cold questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Dextromethorphan and guaifenesin (daytime); dextromethorphan and doxylamine (nighttime)
- What this could lead to
- If the results are positive, this could confirm that these over-the-counter cough syrups help people feel better and function more normally while they have a cold.
- What could go wrong
- This is a completed real-world study, not a tightly controlled trial, so results may be influenced by factors like how people naturally recover from a cold. The findings are unlikely to change standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMON COLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lindus Health Limited
New York, New York, 10017, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breathing test unlock the secrets of chronic cough?
- Could a new dissolving tablet quiet coughs? safety trial begins
- New pill aims to silence chronic cough that Won't quit
- Asthma in children may hide behind unusual symptoms, study reveals
- New cough drug candidate camlipixant tested in healthy volunteers
- New opioid aims to quiet cough during anesthesia